Amy Walker
Vermogen: 345 063 $ op 31-05-2026
Vermogen: 345 063 $ op 31-05-2026
Dr. Amy J.
Walker is a Chief Executive Officer & Director at 4basebio Plc.
She is on the Board of Directors at 4basebio Plc, Heqet Therapeutics Srl and Neomatrix SRL.
She received her doctorate degree from McGill University and a doctorate degree from the University of British Columbia.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
4BASEBIO PLC 0,31% | 21-05-2026 | 48.529 ( 0,31% ) | 345 063 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| 4BASEBIO PLC | Algemeen Directeur | 10-02-2026 |
Heqet Therapeutics SRL
Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company specializes in cardiac regenerative medicine | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4basebio Plc
4basebio Plc BiotechnologyHealth Technology Develops gene therapy technologies and manufactures synthetic DNA | Health Technology |
Heqet Therapeutics SRL
Heqet Therapeutics SRL Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company specializes in cardiac regenerative medicine | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau